Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17480 | 533 | 37.9 | 69% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | IMMUNE SUPPRESSOR CELLS | Author keyword | 14 | 100% | 1% | 7 |
| 2 | IRX 2 | Author keyword | 11 | 67% | 2% | 10 |
| 3 | SERV 151Z2 | Address | 5 | 50% | 1% | 7 |
| 4 | TUMOR BEARERS | Author keyword | 2 | 67% | 0% | 2 |
| 5 | HNSCC PATIENTS | Author keyword | 1 | 50% | 0% | 2 |
| 6 | IMMUNE REGRESSION | Author keyword | 1 | 100% | 0% | 2 |
| 7 | OTOLARYNGOL HEAD NECK SURG CANC | Address | 1 | 50% | 0% | 2 |
| 8 | SERV 151 Z2 | Address | 1 | 33% | 0% | 2 |
| 9 | CARCINOMA OF THE PHARYNX | Author keyword | 1 | 50% | 0% | 1 |
| 10 | CONCONAVALIN A | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | IMMUNE SUPPRESSOR CELLS | 14 | 100% | 1% | 7 | Search IMMUNE+SUPPRESSOR+CELLS | Search IMMUNE+SUPPRESSOR+CELLS |
| 2 | IRX 2 | 11 | 67% | 2% | 10 | Search IRX+2 | Search IRX+2 |
| 3 | TUMOR BEARERS | 2 | 67% | 0% | 2 | Search TUMOR+BEARERS | Search TUMOR+BEARERS |
| 4 | HNSCC PATIENTS | 1 | 50% | 0% | 2 | Search HNSCC+PATIENTS | Search HNSCC+PATIENTS |
| 5 | IMMUNE REGRESSION | 1 | 100% | 0% | 2 | Search IMMUNE+REGRESSION | Search IMMUNE+REGRESSION |
| 6 | CARCINOMA OF THE PHARYNX | 1 | 50% | 0% | 1 | Search CARCINOMA+OF+THE+PHARYNX | Search CARCINOMA+OF+THE+PHARYNX |
| 7 | CONCONAVALIN A | 1 | 50% | 0% | 1 | Search CONCONAVALIN+A | Search CONCONAVALIN+A |
| 8 | EP RECEPTOR ANTAGONISTS | 1 | 50% | 0% | 1 | Search EP+RECEPTOR+ANTAGONISTS | Search EP+RECEPTOR+ANTAGONISTS |
| 9 | GLANDULAR HYPERTROPHY | 1 | 50% | 0% | 1 | Search GLANDULAR+HYPERTROPHY | Search GLANDULAR+HYPERTROPHY |
| 10 | HPV HUMAN PAPILLOMA VIRUS | 1 | 50% | 0% | 1 | Search HPV+HUMAN+PAPILLOMA+VIRUS | Search HPV+HUMAN+PAPILLOMA+VIRUS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CYTOKINE MIXTURE IRX 2 | 15 | 88% | 1% | 7 |
| 2 | PERILYMPHATIC INTERLEUKIN 2 | 6 | 80% | 1% | 4 |
| 3 | IMMUNE SUPPRESSOR CELLS | 4 | 67% | 1% | 4 |
| 4 | PULSE THERAPY SCHEDULE | 4 | 67% | 1% | 4 |
| 5 | SUPPRESSIVE CD34 CELLS | 4 | 75% | 1% | 3 |
| 6 | TREATED AGED MICE | 3 | 100% | 1% | 3 |
| 7 | LOCAL ADOPTIVE IMMUNOTHERAPY | 3 | 60% | 1% | 3 |
| 8 | COMBINATION NONVIRAL INTERLEUKIN 2 | 2 | 67% | 0% | 2 |
| 9 | FRAGMENT SPHEROIDS | 2 | 67% | 0% | 2 |
| 10 | IMMUNE SUPPRESSOR | 2 | 67% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Cytokines in head and neck cancer | 2006 | 48 | 51 | 41% |
| Protective mechanisms of head and neck squamous cell carcinomas from immune assault | 2006 | 38 | 88 | 28% |
| The clinical implications of antitumor immunity in head and neck cancer | 2012 | 13 | 200 | 16% |
| Covalent linking of proteins and cytokines to suture: Enhancing the immune response of head and neck cancer patients | 2003 | 9 | 105 | 59% |
| Role of cytokines in head and neck squamous cell carcinoma | 2006 | 25 | 88 | 31% |
| IMMUNOMODULATION THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK | 1993 | 19 | 21 | 71% |
| Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck | 2004 | 27 | 127 | 31% |
| Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy | 2012 | 14 | 143 | 12% |
| Immunotherapy for head and neck cancer: advances and deficiencies | 2011 | 6 | 81 | 25% |
| The immunopharmacology of head and neck cancer: An update | 1997 | 30 | 116 | 42% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SERV 151Z2 | 5 | 50% | 1.3% | 7 |
| 2 | OTOLARYNGOL HEAD NECK SURG CANC | 1 | 50% | 0.4% | 2 |
| 3 | SERV 151 Z2 | 1 | 33% | 0.4% | 2 |
| 4 | IMMUNOL TRANSFUS MES | 1 | 50% | 0.2% | 1 |
| 5 | KATEDRA KLIN OTOLARYNGOL | 1 | 50% | 0.2% | 1 |
| 6 | BROEGELMANN MICROBIOL | 1 | 18% | 0.6% | 3 |
| 7 | IMMUNOTHER Y TREATMENT | 1 | 25% | 0.4% | 2 |
| 8 | HEMATO PATHOL | 0 | 33% | 0.2% | 1 |
| 9 | MED TUMOUR IMMUNOL | 0 | 33% | 0.2% | 1 |
| 10 | MICROSCOPY MOL IMAGING CMMI | 0 | 33% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000218652 | BOVINE BETALACTOGLOBULIN//MUCOSAL ANTIGENS//BR AMBEDKAR ROTARY CANC HOSP |
| 2 | 0.0000182106 | CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN |
| 3 | 0.0000166845 | P15E//CKS 17//ADV MED TREATMENTS |
| 4 | 0.0000159876 | WHOLE BLOOD CELL CULTURES//COLORIMETRY METHOD//HUMAN COLORECTAL TUMORS |
| 5 | 0.0000142545 | WARD COLON TUMOR//MAIF//MAMMARY TUMOR BEARERS |
| 6 | 0.0000134008 | TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY |
| 7 | 0.0000131097 | UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT |
| 8 | 0.0000116658 | UNITA OPERAT ASSISTENZIALE GINECOL ONCOL//CD1A//CDLA |
| 9 | 0.0000087705 | MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELL |
| 10 | 0.0000081181 | ACUTE MORBILLI INFECTION//// |